Cost-sharing deal may make cancer drugs more accessible

03/13/2014 | Bloomberg

Roche Holding is testing a cost-sharing program with provincial governments in China that could make cancer drugs accessible to more people. Under the deal, Roche donates eight vials of its breast cancer drug Herceptin to patients after they have purchased six vials of the drug, which the provincial government has begun subsidizing. The drug is not covered by China's public health insurance program, but the number of patients in China taking the drug quadrupled in 2012, thanks in part to the cost-sharing arrangement.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR